326 related articles for article (PubMed ID: 27318116)
21. Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases.
Arruda LC; Clave E; Moins-Teisserenc H; Douay C; Farge D; Toubert A
Curr Res Transl Med; 2016; 64(2):107-13. PubMed ID: 27316394
[TBL] [Abstract][Full Text] [Related]
22. Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial.
Mancardi GL; Sormani MP; Gualandi F; Saiz A; Carreras E; Merelli E; Donelli A; Lugaresi A; Di Bartolomeo P; Rottoli MR; Rambaldi A; Amato MP; Massacesi L; Di Gioia M; Vuolo L; Currò D; Roccatagliata L; Filippi M; Aguglia U; Iacopino P; Farge D; Saccardi R; ;
Neurology; 2015 Mar; 84(10):981-8. PubMed ID: 25672923
[TBL] [Abstract][Full Text] [Related]
23. Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis.
Farge D; Henegar C; Carmagnat M; Daneshpouy M; Marjanovic Z; Rabian C; Ilie D; Douay C; Mounier N; Clave E; Bengoufa D; Cabane J; Marolleau JP; Gluckman E; Charron D; Toubert A
Arthritis Rheum; 2005 May; 52(5):1555-63. PubMed ID: 15880600
[TBL] [Abstract][Full Text] [Related]
24. Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation.
Servais S; Lengline E; Porcher R; Carmagnat M; Peffault de Latour R; Robin M; Sicre de Fontebrune F; Clave E; Maki G; Granier C; Xhaard A; Dhedin N; Molina JM; Toubert A; Moins-Teisserenc H; Socie G
Biol Blood Marrow Transplant; 2014 Apr; 20(4):507-17. PubMed ID: 24406505
[TBL] [Abstract][Full Text] [Related]
25. Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant.
Massey JC; Sutton IJ; Ma DDF; Moore JJ
Front Immunol; 2018; 9():410. PubMed ID: 29593711
[TBL] [Abstract][Full Text] [Related]
26. Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis.
Massey J; Jackson K; Singh M; Hughes B; Withers B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I
Front Immunol; 2022; 13():798300. PubMed ID: 35197974
[TBL] [Abstract][Full Text] [Related]
27. Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients.
Arruda LC; Lorenzi JC; Sousa AP; Zanette DL; Palma PV; Panepucci RA; Brum DS; Barreira AA; Covas DT; Simões BP; Silva WA; Oliveira MC; Malmegrim KC
Bone Marrow Transplant; 2015 Mar; 50(3):380-9. PubMed ID: 25486582
[TBL] [Abstract][Full Text] [Related]
28. Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient.
Obradović D; Tukić L; Radovinović-Tasić S; Petrović B; Elez M; Ostojić G; Balint B
Vojnosanit Pregl; 2016 May; 73(5):504-8. PubMed ID: 27430119
[TBL] [Abstract][Full Text] [Related]
29. Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
Atkins HL; Bowman M; Allan D; Anstee G; Arnold DL; Bar-Or A; Bence-Bruckler I; Birch P; Bredeson C; Chen J; Fergusson D; Halpenny M; Hamelin L; Huebsch L; Hutton B; Laneuville P; Lapierre Y; Lee H; Martin L; McDiarmid S; O'Connor P; Ramsay T; Sabloff M; Walker L; Freedman MS
Lancet; 2016 Aug; 388(10044):576-85. PubMed ID: 27291994
[TBL] [Abstract][Full Text] [Related]
30. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.
Burt RK; Balabanov R; Han X; Sharrack B; Morgan A; Quigley K; Yaung K; Helenowski IB; Jovanovic B; Spahovic D; Arnautovic I; Lee DC; Benefield BC; Futterer S; Oliveira MC; Burman J
JAMA; 2015 Jan; 313(3):275-84. PubMed ID: 25602998
[TBL] [Abstract][Full Text] [Related]
31. Autologous Hematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: A Real-world Case Series.
Nicholas RS; Rhone EE; Mariottini A; Silber E; Malik O; Singh-Curry V; Turner B; Scalfari A; Ciccarelli O; Sormani MP; Olavarria E; Mehra V; Gabriel I; Kazmi MA; Muraro P;
Neurology; 2021 Aug; 97(9):e890-e901. PubMed ID: 34253634
[TBL] [Abstract][Full Text] [Related]
32. Defective expression of apoptosis-related molecules in multiple sclerosis patients is normalized early after autologous haematopoietic stem cell transplantation.
de Oliveira GL; Ferreira AF; Gasparotto EP; Kashima S; Covas DT; Guerreiro CT; Brum DG; Barreira AA; Voltarelli JC; Simões BP; Oliveira MC; de Castro FA; Malmegrim KC
Clin Exp Immunol; 2017 Mar; 187(3):383-398. PubMed ID: 28008595
[TBL] [Abstract][Full Text] [Related]
33. Autologous hematopoietic stem cell transplantation in systemic sclerosis induces long-lasting changes in B cell homeostasis toward an anti-inflammatory B cell cytokine pattern.
Gernert M; Tony HP; Schwaneck EC; Gadeholt O; Schmalzing M
Arthritis Res Ther; 2019 Apr; 21(1):106. PubMed ID: 31036055
[TBL] [Abstract][Full Text] [Related]
34. Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two cases.
Portaccio E; Amato MP; Siracusa G; Pagliai F; Sorbi S; Guidi S; Bosi A; Saccardi R
Mult Scler; 2007 Jun; 13(5):676-8. PubMed ID: 17548451
[TBL] [Abstract][Full Text] [Related]
35. Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An Update.
Lutter L; Spierings J; van Rhijn-Brouwer FCC; van Laar JM; van Wijk F
Front Immunol; 2018; 9():767. PubMed ID: 29731752
[TBL] [Abstract][Full Text] [Related]
36. Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant.
Massey J; Visweswaran M; Khoo M; Hendrawan K; Sutton I; Withers B; Ma D; Moore J
Cytotherapy; 2023 Dec; 25(12):1271-1276. PubMed ID: 37737765
[TBL] [Abstract][Full Text] [Related]
37. MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS.
Saiz A; Carreras E; Berenguer J; Yagüe J; Martínez C; Marín P; Rovira M; Pujol T; Arbizu T; Graus F
Neurology; 2001 Apr; 56(8):1084-9. PubMed ID: 11320183
[TBL] [Abstract][Full Text] [Related]
38. Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients.
Vaivade A; Wiberg A; Khoonsari PE; Carlsson H; Herman S; Al-Grety A; Freyhult E; Olsson-Strömberg U; Burman J; Kultima K
Lipids Health Dis; 2023 Jul; 22(1):97. PubMed ID: 37420217
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic and functional lymphocyte recovery after CD34+-enriched versus non-T cell-depleted autologous peripheral blood stem cell transplantation.
Nachbaur D; Kropshofer G; Heitger A; Lätzer K; Glassl H; Ludescher C; Nussbaumer W; Niederwieser D
J Hematother Stem Cell Res; 2000 Oct; 9(5):727-36. PubMed ID: 11091497
[TBL] [Abstract][Full Text] [Related]
40. Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial.
Armand P; Nagler A; Weller EA; Devine SM; Avigan DE; Chen YB; Kaminski MS; Holland HK; Winter JN; Mason JR; Fay JW; Rizzieri DA; Hosing CM; Ball ED; Uberti JP; Lazarus HM; Mapara MY; Gregory SA; Timmerman JM; Andorsky D; Or R; Waller EK; Rotem-Yehudar R; Gordon LI
J Clin Oncol; 2013 Nov; 31(33):4199-206. PubMed ID: 24127452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
